Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
MERRIMACK PHARM (NQ: MACK)
5.200 USD  -0.060 (-1.14%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Stories about MERRIMACK PHARM
 
Thrifty Merrimack developing new cancer drugs at lower cost
May 22, 2013
NEW YORK, May 22 (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction... Read More
category companyNews
from Reuters: Company News
Singh's TPG-Axon Shows New Stake in Agilent (A), Express Scripts (ESRX), FMC (FMC) (more...)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8341315 for the full story. Read More
from StreetInsider.com News Articles
Earnings Scheduled For May 13, 2013
May 13, 2013
China Green Agriculture, Inc. (NYSE: CGA ) is expected to report its Q3 earnings at $0.45 per share on revenue of $84.80 million. China Yuchai International Limited (NYSE: CYD ) is projected to report... Read More
category Earnings , Benzinga , VELT , and 39 more.
from Latest Articles from Benzinga.com
Stocks Hitting 52-Week Lows
May 06, 2013
Merrimack Pharmaceuticals (NASDAQ: MACK ) shares touched a new 52-week low of $4.145. Merrimack' trailing-twelve-month profit margin is -186.58%. Ecopetrol SA (NYSE: EC ) shares reached a new 52-week... Read More
category Benzinga , EBR , 52/Week Lows , and 7 more.
from Latest Articles from Benzinga.com
Merrimack Pharmaceuticals Getting Very Oversold (MACK)
April 24, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
8 Biotechnology Stocks to Sell Now
April 17, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Merrimack Pharmaceuticals (MACK) Completes Enrollment in Phase 2 Study of MM-121 in HER2-Negative Breast Cancer
April 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8251886 for the full story. Read More
from StreetInsider.com News Articles
Merrimack Pharmaceuticals' Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
April 10, 2013
Merrimack Pharmaceuticals (NASDAQ: MACK ) today announced preclinical study results showing that the novel bispecific therapy MM-111 restored tumor sensitivity to the chemotherapy agent, paclitaxel,... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Streetinsider.com Pre-Market Movers 04/04: (ALU) (PSDV) (NAVB) Higher; (MACK) (CPWR) (LSE) Lower
April 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8233428 for the full story. Read More
from StreetInsider.com News Articles
Merrimack lung cancer drug fails goal in one mid-stage trial group
April 04, 2013
April 4 (Reuters) - Merrimack Pharmaceuticals Inc said one of three patient groups in a mid-stage trial of its experimental lung cancer drug failed to meet the main goal of improving survival rates... Read More
category companyNews
from Reuters: Company News
Merrimack Pharm (MACK) Posts Wider than Expected Q4 Loss
March 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8184380 for the full story. Read More
from StreetInsider.com News Articles
Merrimack Pharma (MACK) Files $200M Mixed Shelf
February 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8051184 for the full story. Read More
from StreetInsider.com News Articles
Merrimack Pharma (MACK) Will Present Preclinical Data for MM-111
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8025027 for the full story. Read More
from StreetInsider.com News Articles
Tuesday 12/18 Insider Buying Report: NGL, MACK
December 18, 2012
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... Read More
category Stocks
from Market News Video
Singh's TPG-Axon Enters Dollar General (DG), GNC (GNC), Green Mountain (GMCR), (more...)
November 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7878383 for the full story. Read More
from StreetInsider.com News Articles
Merrimack Pharm (MACK) Reports Q3 Loss of $1.81
November 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7874851 for the full story. Read More
from StreetInsider.com News Articles
(AEGR) (GEVA) (MACK) (SUPN) (XOMA) (ZGNX) to be Added to NASDAQ Biotechnology Index (IBB)
November 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7865465 for the full story. Read More
from StreetInsider.com News Articles
Guggenheim Starts Merrimack Pharmaceuticals (MACK) at Buy
November 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7861764 for the full story. Read More
from StreetInsider.com News Articles
Brean Murray Carret & Co. Starts Merrimack Pharmaceuticals (MACK) at Buy, MM-398 and More...
September 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7753567 for the full story. Read More
from StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 09/25: (PPHM) (GENE) (HMPR) Higher; (GEVO) (MACK) (OMEX) Lower
September 25, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7749550 for the full story. Read More
from StreetInsider.com News Articles
Tuesday 9/18 Insider Buying Report: MACK, DEI
September 18, 2012
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... Read More
category Stocks
from Market News Video
Tuesday 8/28 Insider Buying Report: DTE, MACK
August 28, 2012
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... Read More
category Stocks
from Market News Video
Elan Corporation, plc (ADR) and More Big Movers in Healthcare Today
August 13, 2012
The market is having a bad day so far. The Nasdaq has declined 0.3%; the S&P 500 is down 0.4%; and the Dow has decreased 0.5%. The healthcare sector is the category of stocks relating to medical and h... Read More
from Investopedia Advisor Commentary
Merrimack Pharm (MACK) Posts Narrower than Expected Q2 Loss of 22c/Share
August 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7649685 for the full story. Read More
from StreetInsider.com News Articles
Stocks to watch Friday: Goldman, Bally, Scotts
August 10, 2012
MarketWatch’s rundown of corporate headlines of interest to investors early Friday. Read More
category S , Biotechnology , Banks , and 40 more.
from MarketWatch
Big Movers on the Healthcare Sector Today, Including VVUS
July 20, 2012
The morning has been bad for the market. The Nasdaq is down 0.7%; the S&P 500 has slipped 0.7%; and the Dow has decreased 0.8%. The healthcare sector is the category of stocks relating to medical and... Read More
from Investopedia Advisor Commentary
Merrimack Pharmaceuticals (MACK) Adds John Mendelsohn to Board of Directors
June 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7524451 for the full story. Read More
from StreetInsider.com News Articles
Merrimack Pharmaceuticals Inc. Becomes Oversold (MACK)
June 05, 2012
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Cowen Starts Merrimack Pharmaceuticals (MACK) at Outperform
May 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7413639 for the full story. Read More
from StreetInsider.com News Articles
Oppenheimer Starts Merrimack Pharmaceuticals (MACK) at Outperform, $12 Target
May 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7412058 for the full story. Read More
from StreetInsider.com News Articles
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here